Biofil Chemicals & Pharmaceuticals profit increases 327.19% in (Q2) FY 2020-21

Source

Team Infinities:

Biofil Chemicals & Pharmaceuticals Limited NSE Symbol:BIOFILCHEM, BSE Security Code:524396 has declared its 2nd(second) quarter unaudited standalone financial report from the month of July, 2020 to the month of September, 2020; for the fiscal year 2020-21.

Revenue Reported by Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Current Quarter (July, 2020 - September, 2020) Previous Quarter (April, 2020 - June, 2020) Corresponding Quarter (July, 2019 - September, 2019) 6 Months Ended (April, 2020 - September, 2020) Corresponding 6 Months Ended (April, 2019 - September, 2019)
161.65 29.37 116.62 191.02 132.68
Calculated Revenue of Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Current(September, 2020) VS Previous(June, 2020) Current(September, 2020) VS Corresponding(September, 2019) 6 months Ended(April, 2020 - September, 2020) VS Corresponding 6 months Ended(April, 2019 - September, 2019)
Change Change % Change Change % Change Change %
132.28 450.39%(Revenue Increase) 45.03 38.61%(Revenue Increase) 58.34 43.97%(Revenue Increase)

Revenue: Biofil Chemicals & Pharmaceuticals Limited's financial report shows that the company's revenue increased by 450.39% in QoQ(Quarter on Quarter) / current quarter(July, 2020 - September, 2020) for revenue increase of Rs.132.28 millions, as the company posted revenue of Rs.161.65 millions; in compare to previous quarter(April, 2020 - June, 2020) when the company reported revenue of Rs.29.37 millions.
The result also shows that the company's revenue increased by 38.61% in YoY(Year over Year) / in current quarter(July, 2020 - September, 2020) for revenue increase of Rs.45.03 millions; in compare to corresponding quarter(July, 2019 - September, 2019) when the company posted revenue of Rs.116.62 millions.
The company also reported that its revenue increased by 43.97% in 6 months end(April, 2020 - September, 2020) for revenue increase of Rs.58.34 millions, since the company reported revenue of Rs.191.02 millions; in compare to corresponding 6 months end(April, 2019 - September. 2019) when the company posted revenue of Rs.132.68 millions.

Gross Margin(%) Reported by Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Current Quarter (July, 2020 - September, 2020) Previous Quarter (April, 2020 - June, 2020) Corresponding Quarter (July, 2019 - September, 2019) 6 Months Ended (April, 2020 - September, 2020) Corresponding 6 Months Ended (April, 2019 - September, 2019)
164.81 974.14(Negative) 194.33(Negative) 21.75 168.35(Negative)
Calculated Gross Margin(%) of Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Current(September, 2020) VS Previous(June, 2020) Current(September, 2020) VS Corresponding(September, 2019) 6 months Ended(April, 2020 - September, 2020) VS Corresponding 6 months Ended(April, 2019 - September, 2019)
Change Change % Change Change % Change Change %
1138.95 116.92%(GM Increase) 359.14 184.81%(GM Increase) 190.09 112.92%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 116.92% in QoQ(Quarter on Quarter) / current quarter(July, 2020 - September, 2020) for 1138.95% GM increase, as the company reported 164.81% GM; in compare to previous quarter(April, 2020 - June, 2020) when the company reported 974.14% Negative GM.
The result also indicates, the company's GM increased by 184.81% in YoY(Year over Year) / in current quarter(July, 2020 - September, 2020) for 359.14% GM increase; in compare to corresponding quarter(July, 2019 - September, 2019) when the company reported 194.33% Negative GM.
The company also reported that its GM increased by 112.92% in 6 months end(April, 2020 - September, 2020) for 190.09% GM increase, since the company reported 21.75% GM; in compare to corresponding 6 months end(April, 2019 - September. 2019) when the company reported 168.35% Negative GM.

EBITDA Reported by Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Current Quarter (July, 2020 - September, 2020) Previous Quarter (April, 2020 - June, 2020) Corresponding Quarter (July, 2019 - September, 2019) 6 Months Ended (April, 2020 - September, 2020) Corresponding 6 Months Ended (April, 2019 - September, 2019)
10.56 3.44 9.19 14.00 10.85
Calculated EBITDA of Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Current(September, 2020) VS Previous(June, 2020) Current(September, 2020) VS Corresponding(September, 2019) 6 months Ended(April, 2020 - September, 2020) VS Corresponding 6 months Ended(April, 2019 - September, 2019)
Change Change % Change Change % Change Change %
7.12 206.98%(EBITDA Increase) 1.37 14.91%(EBITDA Increase) 3.15 29.03%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 206.98% in QoQ(Quarter on Quarter) / current quarter(July, 2020 - September, 2020) for EBITDA increase of Rs.7.12 millions, as the company posted EBITDA of Rs.10.56 millions; in compare to previous quarter(April, 2020 - June, 2020) when the company reported EBITDA of Rs.3.44 millions.
The result also shows that the company's EBITDA increased by 14.91% in YoY(Year over Year) / in current quarter(July, 2020 - September, 2020) for EBITDA increase of Rs.1.37 millions; in compare to corresponding quarter(July, 2019 - September, 2019) when the company posted EBITDA of Rs.9.19 millions.
The company also reported that its EBITDA increased by 29.03% in 6 months end(April, 2020 - September, 2020) for EBITDA increase of Rs.3.15 millions, since the company reported EBITDA of Rs.14.00 millions; in compare to corresponding 6 months end(April, 2019 - September. 2019) when the company posted EBITDA of Rs.10.85 millions.

Profit and Loss Reported by Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Current Quarter (July, 2020 - September, 2020) Previous Quarter (April, 2020 - June, 2020) Corresponding Quarter (July, 2019 - September, 2019) 6 Months Ended (April, 2020 - September, 2020) Corresponding 6 Months Ended (April, 2019 - September, 2019)
9.27(Profit ) 2.17(Profit ) 7.91(Profit ) 11.44(Profit ) 8.30(Profit )
Calculated Profit and Loss of Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Current(September, 2020) VS Previous(June, 2020) Current(September, 2020) VS Corresponding(September, 2019) 6 months Ended(April, 2020 - September, 2020) VS Corresponding 6 months Ended(April, 2019 - September, 2019)
Change Change % Change Change % Change Change %
7.10 327.19%(Profit Increase) 1.36 17.19%(Profit Increase) 3.14 37.83%(Profit Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 327.19% in QoQ(Quarter on Quarter) / current quarter(July, 2020 - September, 2020) for profit increase of Rs.7.10 millions, as the company posted profit of Rs.9.27 millions; in compare to previous quarter(April, 2020 - June, 2020) when the company reported profit of Rs.2.17 millions.
The result also shows that the company's profit increased by 17.19% in YoY(Year over Year) / in current quarter(July, 2020 - September, 2020) for profit increase of Rs.1.36 millions; in compare to corresponding quarter(July, 2019 - September, 2019) when the company posted profit of Rs.7.91 millions.
The company also reported that its profit increased by 37.83% in 6 months end(April, 2020 - September, 2020) for profit increase of Rs.3.14 millions, since the company reported profit of Rs.11.44 millions; in compare to corresponding 6 months end(April, 2019 - September. 2019) when the company posted profit of Rs.8.30 millions.

EPS Reported by Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Current Quarter (July, 2020 - September, 2020) Previous Quarter (April, 2020 - June, 2020) Corresponding Quarter (July, 2019 - September, 2019) 6 Months Ended (April, 2020 - September, 2020) Corresponding 6 Months Ended (April, 2019 - September, 2019)
0.57 0.13 0.49 0.70 0.51
Calculated EPS of Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Current(September, 2020) VS Previous(June, 2020) Current(September, 2020) VS Corresponding(September, 2019) 6 months Ended(April, 2020 - September, 2020) VS Corresponding 6 months Ended(April, 2019 - September, 2019)
Change Change % Change Change % Change Change %
0.44 338.46%(EPS Increase) 0.08 16.33%(EPS Increase) 0.19 37.25%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 338.46% in QoQ(Quarter on Quarter) / current quarter(July, 2020 - September, 2020) for EPS increase of Rs.0.44, as the company posted EPS of Rs.0.57; in compare to previous quarter(April, 2020 - June, 2020) when the company reported EPS of Rs.0.13.
The result also shows that the company's EPS increased by 16.33% in YoY(Year over Year) / in current quarter(July, 2020 - September, 2020) for EPS increase of Rs.0.08; in compare to corresponding quarter(July, 2019 - September, 2019) when the company posted EPS of Rs.0.49.
The company also reported that its EPS increased by 37.25% in 6 months end(April, 2020 - September, 2020) for EPS increase of Rs.0.19, since the company reported EPS of Rs.0.70; in compare to corresponding 6 months end(April, 2019 - September. 2019) when the company posted EPS of Rs.0.51.

Assets Reported by Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Details Non-current Assets Current Assets
Current Year Ended(September, 2020) Previous Year End(March, 2020) Current Year Ended(September, 2020) Previous Year End(March, 2020)
Reported 100.14 100.93 242.37 322.72
  Change Change % Change Change %
Calculated 0.79 0.78%(Assets Decrease) 80.35 24.90%(Assets Decrease)

Assets:The company reported its non-current assets decreased by 0.78% in current quarter(September, 2020) for non-current assets decrease of Rs.0.79 million, since the company reported net non-current assets of Rs.100.14 millions; in compare to previous year end(March, 2020) when the company reported net non-current assets of Rs.100.93 millions.
The balance sheet of the company also shows that, its current assets decreased by 24.90% in current quarter(September, 2020) for current assets decrease of Rs.80.35 millions, as the company reported net current assets of Rs.242.37 millions; against previous year end(March, 2020) when the company reported net current assets of Rs.322.72 millions.

Liabilities Reported by Biofil Chemicals & Pharmaceuticals Limited for Second Quarter FY, 2020-21
Details Non-current Liabilities Current Liabilities
Current Year Ended(September, 2020) Previous Year End(March, 2020) Current Year Ended(September, 2020) Previous Year End(March, 2020)
Reported 160.27 148.83 182.23 274.82
  Change Change % Change Change %
Calculated 11.44 7.69%(Liabilities Increase) 92.59 33.69%(Liabilities Decrease)

Liabilities:The company reported its non-current liabilities increased by 7.69% in current quarter(September, 2020) for non-current liabilities increase of Rs.11.44 millions, since the company reported net non-current liabilities of Rs.160.27 millions; in compare to previous year end(March, 2020) when the company reported net non-current liabilities of Rs.148.83 millions.
The balance sheet of the company also shows that, its current liabilities decreased by 33.69% in current quarter(September, 2020) for current liabilities decrease of Rs.92.59 millions, as the company reported net current liabilities of Rs.182.23 millions; against previous year end(March, 2020) when the company reported net current liabilities of Rs.274.82 millions.

 


***All amounts are given in Million Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.